FDA approves PharmaEssentia interferon drug for a rare type of blood cancer
Polycythemia vera, a rare blood cancer characterized by the overproduction of red blood cells, now has its first FDA-approved drug treatment. The agency awarded the […]
Polycythemia vera, a rare blood cancer characterized by the overproduction of red blood cells, now has its first FDA-approved drug treatment. The agency awarded the […]
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
President says agreement with German firm BioNTech has been delayed after Beijing intervention Coronavirus – latest updates See all our coronavirus coverage Taiwan’s president has […]
Shots: The Taiwan Ministry of Health and Welfare granted conditional approval to initiate P-II trial of UB-612 in 3,850 subjects including adolescents, adults, and seniors […]
Shots: Health2Sync reported the results of their clinical study in Taiwan, demonstrating that integrating Fitbit wearable devices with their Health2Sync patient management platform can help […]
Copyright © 2024 | WordPress Theme by MH Themes